Square Enix has had a rough couple of years—combining $140 million in losses from abandoned projects, the shine slowly fading from Final Fantasy 14 (even if it does look like things are on the up, ...

[NEW YORK] As McKinsey partners gathered in the consulting giant’s birthplace in late October, Bob Sternfels delivered a rallying cry. “We will kick some ass as we start our second century,” the ...

Xero Ltd (XRO) reported its Q1 2025 earnings, revealing a notable divergence between expected and actual financial performance. The company posted an earnings per share (EPS) of $0.83, falling short ...

Shunting in NPH, a novel drug for narcolepsy, and new approaches in multiple sclerosis are among the top picks from Professor Diener.